公开(公告)号：US20150361050A1

公开(公告)日：2015-12-17

申请号：US14736690

申请日：2015-06-11

Applicant: Gilead Sciences, Inc.

Inventor： Brandon H. Brown ,  Ernest A. Carra ,  Jeffrey N. Hemenway ,  Henry Morrison ,  Troy Reynolds ,  Bing Shi ,  Dimitrios Stefanidis ,  Fang Wang ,  Matthew Robert Warr ,  James Andrew Whitney ,  Yan Xin

IPC: C07D239/42

CPC classification number: C07D239/42 ,  A61K31/535 ,  A61K31/5377 ,  C07B2200/13 ,  C07D265/30

Abstract: The present invention relates to stable novel salt forms of N-(cyanomethyl)-4-(2-(4-morpholinophenylamino)pyrimidin-4-yl)benzamide that are suitable for the preparation of pharmaceutical formulations thereof, and their therapeutic use.

Abstract translation: 本发明涉及适用于制备其药物制剂的N-（氰基甲基）-4-（2-（4-吗啉代苯基氨基）嘧啶-4-基）苯甲酰胺的稳定的新型盐及其治疗用途。